Isoprostanes and Isofurans in Infertility and Assisted Reproduction: What Do We Know So Far?
Abstract
1. Introduction
2. Materials and Methods
3. The Biochemical Synthesis of Isoprostanes and Isofurans
3.1. Lipid Peroxidation and Oxidative Stress in Cellular Membranes
3.2. Synthesis of F2-Isoprostanes from Arachidonic Acid
3.3. Isofurans and the Impact of Oxygen Tension and Mitochondrial Dysfunction
4. Identification and Quantification of Isoprostanes and Isofurans
4.1. Analytical Methods for Quantifying Lipid Peroxidation Products
4.2. Biological Matrices Relevant to Reproductive Physiology
4.3. Biochemical Advantages Compared to Conventional Oxidative Stress Biomarkers
5. Isoprostanes in Male Infertility
5.1. The Composition of Lipids in the Sperm Membrane and Their Susceptibility to Oxidative Stress-Induced Damage
5.2. The Impact on Sperm DNA Integrity and Mitochondrial Function
6. Isoprostanes and Female Infertility
6.1. Oxidative Stress in the Ovarian Microenvironment
6.2. Identification of Isoprostanes in Follicular Fluid
7. Mitochondrial Dysfunction and Isofurans in Reproductive Biology
7.1. Oxygen-Dependent Lipid Peroxidation Pathways
7.2. Mitochondrial Origins of Reactive Oxygen Species
7.3. Isofurans as Biomarkers of Mitochondrial Oxidative Stress in Gametes
8. Clinical Implications in Assisted Reproduction
8.1. Oxidative Lipid Damage as a Contributor to Gamete Competence
8.2. The Potential of Biomarkers in Assessing the Reproductive Microenvironment
8.3. Effects on Treatment Methods Focusing on Oxidative Stress
9. Discussion
10. Limitations of the Current Evidence
11. Conclusions
Author Contributions
Funding
Data Availability Statement
Conflicts of Interest
References
- Venkatesh, S.S.; Wittemans, L.B.L.; Palmer, D.S.; Baya, N.A.; Ferreira, T.; Hill, B.; Lassen, F.H.; Parker, M.J.; Reibe, S.; Elhakeem, A.; et al. Genome-wide analyses identify 25 infertility loci and relationships with reproductive traits across the allele frequency spectrum. Nat. Genet. 2025, 57, 1107–1118. [Google Scholar] [CrossRef]
- Voros, C.; Chatzinikolaou, F.; Papadimas, G.; Polykalas, S.; Sapantzoglou, I.; Koulakmanidis, A.-M.; Athanasiou, D.; Kanaka, V.; Kanaka, M.; Bananis, K.; et al. Oxidative Stress–Telomere Axis in IVF: Molecular Mechanisms, Biomarkers, and Clinical Translation. Int. J. Mol. Sci. 2025, 26, 11359. [Google Scholar] [CrossRef]
- Birben, E.; Sahiner, U.M.; Sackesen, C.; Erzurum, S.; Kalayci, O. Oxidative Stress and Antioxidant Defense. World Allergy Organ. J. 2012, 5, 9–19. [Google Scholar] [CrossRef]
- Sengupta, P.; Pinggera, G.; Calogero, A.E.; Agarwal, A. Oxidative stress affects sperm health and fertility—Time to apply facts learned at the bench to help the patient: Lessons for busy clinicians. Reprod. Med. Biol. 2024, 23, e12598. [Google Scholar] [CrossRef] [PubMed]
- Zheng, Y.; Sun, J.; Luo, Z.; Li, Y.; Huang, Y. Emerging mechanisms of lipid peroxidation in regulated cell death and its physiological implications. Cell Death Dis. 2024, 15, 859. [Google Scholar] [CrossRef]
- Wang, Y.; Fu, X.; Li, H. Mechanisms of oxidative stress-induced sperm dysfunction. Front. Endocrinol. 2025, 16, 1520835. [Google Scholar] [CrossRef]
- Voros, C.; Chatzinikolaou, F.; Papadimas, G.; Polykalas, S.; Mavrogianni, D.; Koulakmanidis, A.-M.; Athanasiou, D.; Kanaka, V.; Kanaka, M.; Bananis, K.; et al. Ferroptosis in the Ovarian Follicular Microenvironment: A Redox-Dependent Cell Death Pathway with Emerging Roles in PCOS, Oocyte Quality, and IVF Outcomes. Int. J. Mol. Sci. 2025, 26, 10381. [Google Scholar] [CrossRef] [PubMed]
- Liu, W.; Morrow, J.D.; Yin, H. Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography–mass spectrometry (GC-MS) method. Free Radic. Biol. Med. 2009, 47, 1101–1107. [Google Scholar] [CrossRef] [PubMed]
- Milatovic, D.; Aschner, M. Measurement of Isoprostanes as Markers of Oxidative Stress in Neuronal Tissue. Curr. Protoc. Toxicol. 2009, 39, 12–14. [Google Scholar] [CrossRef]
- Lin, K.; Barnhart, K.; Shaunik, A.; Butts, S.; Fitzgerald, G.A.; Coutifaris, C. Follicular Fluid F2-isoprostanes: A Novel Assessment of Oxidative Stress in IVF Patients. Fertil. Steril. 2005, 84, S47. [Google Scholar] [CrossRef]
- Rosen, M.P.; Johnstone, E.B.; Roberts, L.J.; Cedars, M.I. Follicular fluid isoprostanes—A marker of ovarian aging? Fertil. Steril. 2009, 92, S57–S58. [Google Scholar] [CrossRef]
- Fujimoto, V.Y.; Bloom, M.S.; Huddleston, H.G.; Shelley, W.B.; Ocque, A.J.; Browne, R.W. Correlations of follicular fluid oxidative stress biomarkers and enzyme activities with embryo morphology parameters during in vitro fertilization. Fertil. Steril. 2011, 96, 1357–1361. [Google Scholar] [CrossRef]
- Fessel, J.P.; Jackson Roberts, L. Isofurans: Novel Products of Lipid Peroxidation that Define the Occurrence of Oxidant Injury in Settings of Elevated Oxygen Tension. Antioxid. Redox Signal. 2005, 7, 202–209. [Google Scholar] [CrossRef]
- Kausar, S.; Wang, F.; Cui, H. The Role of Mitochondria in Reactive Oxygen Species Generation and Its Implications for Neurodegenerative Diseases. Cells 2018, 7, 274. [Google Scholar] [CrossRef]
- Sasaki, H.; Hamatani, T.; Kamijo, S.; Iwai, M.; Kobanawa, M.; Ogawa, S.; Miyado, K.; Tanaka, M. Impact of Oxidative Stress on Age-Associated Decline in Oocyte Developmental Competence. Front. Endocrinol. 2019, 10, 811. [Google Scholar] [CrossRef] [PubMed]
- Wang, T.; Xu, P.; Yuan, J.; Chen, H.; Guo, X.; Gao, J.; Wang, Y.; Yao, D.; Li, X.; Liu, B.; et al. Mitochondrial dysfunction in oocytes: Implications for fertility and ageing. J. Ovarian Res. 2025, 18, 186. [Google Scholar] [CrossRef] [PubMed]
- Collodel, G.; Noto, D.; Signorini, C.; Gambera, L.; Stendardi, A.; Mahmutbegovic, A.; Micheli, L.; Menchiari, A.; Moretti, E. Do Seminal Isoprostanes Have a Role in Assisted Reproduction Outcome? Life 2021, 11, 675. [Google Scholar] [CrossRef]
- De Almeida, A.J.P.O.; De Oliveira, J.C.P.L.; Da Silva Pontes, L.V.; De Souza Júnior, J.F.; Gonçalves, T.A.F.; Dantas, S.H.; De Almeida Feitosa, M.S.; Silva, A.O.; De Medeiros, I.A. ROS: Basic Concepts, Sources, Cellular Signaling, and its Implications in Aging Pathways. Oxidative Med. Cell. Longev. 2022, 2022, 1225578. [Google Scholar] [CrossRef] [PubMed]
- Pizzino, G.; Irrera, N.; Cucinotta, M.; Pallio, G.; Mannino, F.; Arcoraci, V.; Squadrito, F.; Altavilla, D.; Bitto, A. Oxidative Stress: Harms and Benefits for Human Health. Oxidative Med. Cell Longev. 2017, 2017, 8416763. [Google Scholar] [CrossRef]
- Valgimigli, L. Lipid Peroxidation and Antioxidant Protection. Biomolecules 2023, 13, 1291. [Google Scholar] [CrossRef]
- Juan, C.A.; De La Lastra, J.M.P.; Plou, F.J.; Pérez-Lebeña, E. The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies. Int. J. Mol. Sci. 2021, 22, 4642. [Google Scholar] [CrossRef]
- Gautier, C.; Aurich, C. “Fine feathers make fine birds”—The mammalian sperm plasma membrane lipid composition and effects on assisted reproduction. Anim. Reprod. Sci. 2022, 246, 106884. [Google Scholar] [CrossRef] [PubMed]
- Voros, C.; Athanasiou, D.; Papapanagiotou, I.; Mavrogianni, D.; Varthaliti, A.; Bananis, K.; Athanasiou, A.; Athanasiou, A.; Papadimas, G.; Gkirgkinoudis, A.; et al. Cracking the Code of Oocyte Quality: The Oxidative Stress Link to IVF Success. Int. J. Mol. Sci. 2025, 26, 6377. [Google Scholar] [CrossRef]
- Milne, G.L.; Dai, Q.; Roberts, L.J. The isoprostanes—25 years later. Biochim. Biophys. Acta-Mol. Cell Biol. Lipids 2015, 1851, 433–445. [Google Scholar] [CrossRef] [PubMed]
- Roberts, L.J.; Fessel, J.P.; Davies, S.S. The Biochemistry of the Isoprostane, Neuroprostane, and Isofuran Pathways of Lipid Peroxidation. Brain Pathol. 2006, 15, 143–148. [Google Scholar] [CrossRef]
- Stafforini, D.M.; Sheller, J.R.; Blackwell, T.S.; Sapirstein, A.; Yull, F.E.; McIntyre, T.M.; Bonventre, J.V.; Prescott, S.M.; Roberts, L.J. Release of Free F2-isoprostanes from Esterified Phospholipids Is Catalyzed by Intracellular and Plasma Platelet-activating Factor Acetylhydrolases. J. Biol. Chem. 2006, 281, 4616–4623. [Google Scholar] [CrossRef]
- Miller, E.; Morel, A.; Saso, L.; Saluk, J. Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases. Oxidative Med. Cell. Longev. 2014, 2014, 572491. [Google Scholar] [CrossRef]
- Moretti, E.; Signorini, C.; Menchiari, S.; Liguori, L.; Corsaro, R.; Gambera, L.; Collodel, G. Are F2-isoprostanes a better marker of semen lipid peroxidation than MDA in reproductive pathologies with inflammatory basis? Cytokine 2025, 188, 156889. [Google Scholar] [CrossRef] [PubMed]
- Chen, Y.; Yang, J.; Zhang, L. The Impact of Follicular Fluid Oxidative Stress Levels on the Outcomes of Assisted Reproductive Therapy. Antioxidants 2023, 12, 2117. [Google Scholar] [CrossRef]
- Milne, G.L.; Gao, B.; Terry, E.S.; Zackert, W.E.; Sanchez, S.C. Measurement of F2- isoprostanes and isofurans using gas chromatography–mass spectrometry. Free Radic. Biol. Med. 2013, 59, 36–44. [Google Scholar] [CrossRef]
- Gao, L.; Laude, K.; Cai, H. Mitochondrial pathophysiology, reactive oxygen species, and cardiovascular diseases. Vet. Clin. N. Am. Small Anim. Pract. 2008, 38, 137–155. [Google Scholar] [CrossRef]
- Wen, J.-J.; Garg, N.J. Mitochondrial generation of reactive oxygen species is enhanced at the Qo site of the complex III in the myocardium of Trypanosoma cruzi-infected mice: Beneficial effects of an antioxidant. J. Bioenerg. Biomembr. 2008, 40, 587–598. [Google Scholar] [CrossRef] [PubMed]
- Ito, F.; Sono, Y.; Ito, T. Measurement and Clinical Significance of Lipid Peroxidation as a Biomarker of Oxidative Stress: Oxidative Stress in Diabetes, Atherosclerosis, and Chronic Inflammation. Antioxidants 2019, 8, 72. [Google Scholar] [CrossRef]
- Hörkkö, S.; Bird, D.A.; Miller, E.; Itabe, H.; Leitinger, N.; Subbanagounder, G.; Berliner, J.A.; Friedman, P.; Dennis, E.A.; Curtiss, L.K.; et al. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid–protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Investig. 1999, 103, 117–128. [Google Scholar] [CrossRef] [PubMed]
- Ahluwalia, K.; Ebright, B.; Chow, K.; Dave, P.; Mead, A.; Poblete, R.; Louie, S.G.; Asante, I. Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development. Metabolites 2022, 12, 333. [Google Scholar] [CrossRef]
- Sparvero, L.J.; Amoscato, A.A.; Kochanek, P.M.; Pitt, B.R.; Kagan, V.E.; Bayır, H. Mass-spectrometry based oxidative lipidomics and lipid imaging: Applications in traumatic brain injury. J. Neurochem. 2010, 115, 1322–1336. [Google Scholar] [CrossRef]
- Shahidi, F.; Samarasinghe, A. How to assess antioxidant activity? Advances, limitations, and applications of in vitro, in vivo, and ex vivo approaches. Food Prod. Process Nutr. 2025, 7, 50. [Google Scholar] [CrossRef]
- Basu, S. The enigma of in vivo oxidative stress assessment: Isoprostanes as an emerging target. Scand. J. Food Nutr. 2007, 51, 48–61. [Google Scholar] [CrossRef]
- Eini, F.; Kutenaei, M.A.; Shirzeyli, M.H.; Dastjerdi, Z.S.; Omidi, M.; Novin, M.G. Normal seminal plasma could preserve human spermatozoa against cryopreservation damages in Oligozoospermic patients. BMC Mol. Cell Biol. 2021, 22, 50. [Google Scholar] [CrossRef]
- Evans, E.P.P.; Scholten, J.T.M.; Mzyk, A.; Reyes-San-Martin, C.; Llumbet, A.E.; Hamoh, T.; Arts, E.G.J.M.; Schirhagl, R.; Cantineau, A.E.P. Male subfertility and oxidative stress. Redox Biol. 2021, 46, 102071. [Google Scholar] [CrossRef]
- Pan, Y.; Pan, C.; Zhang, C. Unraveling the complexity of follicular fluid: Insights into its composition, function, and clinical implications. J. Ovarian Res. 2024, 17, 237. [Google Scholar] [CrossRef]
- Sreerangaraja Urs, D.B.; Wu, W.-H.; Komrskova, K.; Postlerova, P.; Lin, Y.-F.; Tzeng, C.-R.; Kao, S.-H. Mitochondrial Function in Modulating Human Granulosa Cell Steroidogenesis and Female Fertility. Int. J. Mol. Sci. 2020, 21, 3592. [Google Scholar] [CrossRef]
- Jeremic, A.; Vasiljevic, M.; Mikovic, Z.; Bukumiric, Z.; Simic, P.; Stanisavljevic, T.; Simic, T.; Djukic, T. Oxidative Homeostasis in Follicular Fluid and Embryo Quality—A Pilot Study. Int. J. Mol. Sci. 2025, 26, 388. [Google Scholar] [CrossRef]
- Walters, J.L.H.; De Iuliis, G.N.; Nixon, B.; Bromfield, E.G. Oxidative Stress in the Male Germline: A Review of Novel Strategies to Reduce 4-Hydroxynonenal Production. Antioxidants 2018, 7, 132. [Google Scholar] [CrossRef]
- Fam, S.; Morrow, J. The Isoprostanes: Unique Products of Arachidonic Acid Oxidation-A Review. Curr. Med. Chem. 2003, 10, 1723–1740. [Google Scholar] [CrossRef] [PubMed]
- Duché, G.; Sanderson, J.M. The Chemical Reactivity of Membrane Lipids. Chem. Rev. 2024, 124, 3284–3330. [Google Scholar] [CrossRef] [PubMed]
- Kankanam Gamage, S.U.; Morimoto, Y. Significance of Mitochondrial Dynamics in Reproductive Physiology: Current and Emerging Horizons in Mitochondrial Therapy for Assisted Reproductive Technologies. Reprod. Med. Biol. 2025, 24, e12672. [Google Scholar] [CrossRef] [PubMed]
- Zarghami, N.; Khosrowbeygi, A. Seminal plasma levels of 15-F2α-isoprostane, malondialdehyde and total homocysteine in normozoospermic and asthenozoospermic males. Indian J. Clin. Biochem. 2005, 20, 86–91. [Google Scholar] [CrossRef]
- Moretti, E.; Signorini, C.; Ferretti, F.; Noto, D.; Collodel, G. A Study to Validate the Relevance of Semen F2-Isoprostanes on Human Male Infertility. Int. J. Environ. Res. Public Health 2022, 19, 1642. [Google Scholar] [CrossRef]
- Collodel, G.; Moretti, E.; Longini, M.; Pascarelli, N.A.; Signorini, C. Increased F2-Isoprostane Levels in Semen and Immunolocalization of the 8-Iso Prostaglandin F2α in Spermatozoa from Infertile Patients with Varicocele. Oxidative Med. Cell. Longev. 2018, 2018, 7508014. [Google Scholar] [CrossRef]
- Shan, S.; Xu, F.; Hirschfeld, M.; Brenig, B. Sperm Lipid Markers of Male Fertility in Mammals. Int. J. Mol. Sci. 2021, 22, 8767. [Google Scholar] [CrossRef]
- Yuan, C.; Wang, J.; Lu, W. Regulation of semen quality by fatty acids in diets, extender, and semen. Front. Vet. Sci. 2023, 10, 1119153. [Google Scholar] [CrossRef] [PubMed]
- Morakinyo, A.; Iranloye, B.; Adegoke, O. Calcium antagonists modulate oxidative stress and acrosomal reaction in rat spermatozoa. Arch. Med. Sci. 2011, 4, 613–618. [Google Scholar] [CrossRef] [PubMed]
- Nowicka-Bauer, K.; Nixon, B. Molecular Changes Induced by Oxidative Stress that Impair Human Sperm Motility. Antioxidants 2020, 9, 134. [Google Scholar] [CrossRef] [PubMed]
- Walczak-Jedrzejowska, R.; Wolski, J.K.; Slowikowska-Hilczer, J. The role of oxidative stress and antioxidants in male fertility. Cent. Eur. J. Urol. 2013, 65, 60–67. [Google Scholar] [CrossRef]
- Signorini, C.; Moretti, E.; Collodel, G. Role of isoprostanes in human male infertility. Syst. Biol. Reprod. Med. 2020, 66, 291–299. [Google Scholar] [CrossRef]
- García-Rodríguez, A.; Gosálvez, J.; Agarwal, A.; Roy, R.; Johnston, S. DNA Damage and Repair in Human Reproductive Cells. Int. J. Mol. Sci. 2018, 20, 31. [Google Scholar] [CrossRef]
- Łuczaj, W.; Skrzydlewska, E. DNA damage caused by lipid peroxidation products. Cell. Mol. Biol. Lett. 2003, 8, 391–413. [Google Scholar]
- Xu, Z.; Yan, Q.; Zhang, K.; Lei, Y.; Zhou, C.; Ren, T.; Gao, N.; Wen, F.; Li, X. Mitochondrial Regulation of Spermatozoa Function: Metabolism, Oxidative Stress and Therapeutic Insights. Animals 2025, 15, 2246. [Google Scholar] [CrossRef]
- Vahedi Raad, M.; Firouzabadi, A.M.; Tofighi Niaki, M.; Henkel, R.; Fesahat, F. The impact of mitochondrial impairments on sperm function and male fertility: A systematic review. Reprod. Biol. Endocrinol. 2024, 22, 83. [Google Scholar] [CrossRef]
- Kim, C.; Slaughter, J.C.; Terry, J.G.; Jacobs, D.R.; Parikh, N.; Appiah, D.; Leader, B.; Moravek, M.B.; Wellons, M.F. Antimüllerian hormone and F2-isoprostanes in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Fertil. Steril. 2020, 114, 646–652. [Google Scholar] [CrossRef] [PubMed]
- Nobles, C.J.; Mendola, P.; Mumford, S.L.; Silver, R.M.; Kim, K.; Perkins, N.J.; Schisterman, E.F. The Relationship of Preconception and Early Pregnancy Isoprostanes with Fecundability and Pregnancy Loss. Epidemiology 2023, 34, 759–766. [Google Scholar] [CrossRef]
- Fontana, J.; Martínková, S.; Petr, J.; Žalmanová, T.; Trnka, J. Metabolic Cooperation in the Ovarian Follicle. Physiol. Res. 2020, 69, 33–48. [Google Scholar] [CrossRef]
- Sugino, N. Reactive oxygen species in ovarian physiology. Reprod. Med. Biol. 2005, 4, 31–44. [Google Scholar] [CrossRef]
- Yan, F.; Zhao, Q.; Li, Y.; Zheng, Z.; Kong, X.; Shu, C.; Liu, Y.; Shi, Y. The role of oxidative stress in ovarian aging: A review. J. Ovarian Res. 2022, 15, 100. [Google Scholar] [CrossRef]
- Gao, Y.; Zou, Y.; Wu, G.; Zheng, L. Oxidative stress and mitochondrial dysfunction of granulosa cells in polycystic ovarian syndrome. Front. Med. 2023, 10, 1193749. [Google Scholar] [CrossRef] [PubMed]
- Collado, M.D.; Andrade, G.M.; Meirelles, F.V.; Silveira, J.C.D.; Perecin, F. Contributions from the ovarian follicular environment to oocyte function. Anim. Reprod. 2018, 15, 261–270. [Google Scholar] [CrossRef]
- Van Der Reest, J.; Nardini Cecchino, G.; Haigis, M.C.; Kordowitzki, P. Mitochondria: Their relevance during oocyte ageing. Ageing Res. Rev. 2021, 70, 101378. [Google Scholar] [CrossRef] [PubMed]
- Brinca, A.T.; Ramalhinho, A.C.; Sousa, Â.; Oliani, A.H.; Breitenfeld, L.; Passarinha, L.A.; Gallardo, E. Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome. Biomedicines 2022, 10, 1254. [Google Scholar] [CrossRef]
- Labuschagne, C.F.; Van Den Broek, N.J.F.; Postma, P.; Berger, R.; Brenkman, A.B. A Protocol for Quantifying Lipid Peroxidation in Cellular Systems by F2-Isoprostane Analysis. PLoS ONE 2013, 8, e80935. [Google Scholar] [CrossRef]
- Liu, S.; Jia, Y.; Meng, S.; Luo, Y.; Yang, Q.; Pan, Z. Mechanisms of and Potential Medications for Oxidative Stress in Ovarian Granulosa Cells: A Review. Int. J. Mol. Sci. 2023, 24, 9205. [Google Scholar] [CrossRef]
- Itri, R.; Junqueira, H.C.; Mertins, O.; Baptista, M.S. Membrane changes under oxidative stress: The impact of oxidized lipids. Biophys. Rev. 2014, 6, 47–61. [Google Scholar] [CrossRef]
- Browne, R.W.; Bloom, M.S.; Shelly, W.B.; Ocque, A.J.; Huddleston, H.G.; Fujimoto, V.Y. Follicular fluid high density lipoprotein-associated micronutrient levels are associated with embryo fragmentation during IVF. J. Assist. Reprod. Genet. 2009, 26, 557–560. [Google Scholar] [CrossRef] [PubMed]
- Shi, Y.-Q.; Zhu, X.-T.; Zhang, S.-N.; Ma, Y.-F.; Han, Y.-H.; Jiang, Y.; Zhang, Y.-H. Premature ovarian insufficiency: A review on the role of oxidative stress and the application of antioxidants. Front. Endocrinol. 2023, 14, 1172481. [Google Scholar] [CrossRef] [PubMed]
- Torkashvand, H.; Shabani, R.; Artimani, T.; Amiri, I.; Pilehvari, S.; Torkashvand, L.; Mehdizadeh, R.; Mehdizadeh, M. Oocyte competence develops: Nuclear maturation synchronously with cytoplasm maturation. Zygote 2024, 32, 421–428. [Google Scholar] [CrossRef] [PubMed]
- Xiao, M.; Zhong, H.; Xia, L.; Tao, Y.; Yin, H. Pathophysiology of mitochondrial lipid oxidation: Role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria. Free Radic. Biol. Med. 2017, 111, 316–327. [Google Scholar] [CrossRef]
- Chen, C.; Huang, Z.; Dong, S.; Ding, M.; Li, J.; Wang, M.; Zeng, X.; Zhang, X.; Sun, X. Calcium signaling in oocyte quality and functionality and its application. Front. Endocrinol. 2024, 15, 1411000. [Google Scholar] [CrossRef]
- Checa, J.; Aran, J.M. Reactive Oxygen Species: Drivers of Physiological and Pathological Processes. J. Inflamm. Res. 2020, 13, 1057–1073. [Google Scholar] [CrossRef]
- Roberts, L.J.; Milne, G.L. Isoprostanes. J. Lipid Res. 2009, 50, S219–S223. [Google Scholar] [CrossRef]
- Fessel, J.P.; Porter, N.A.; Moore, K.P.; Sheller, J.R.; Roberts, L.J. Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proc. Natl. Acad. Sci. USA 2002, 99, 16713–16718. [Google Scholar] [CrossRef]
- Rufián-Henares, J.Á.; Guerra-Hernández, E.; García-Villanova, B. Evolution of Fatty Acid Profile and Lipid Oxidation During Enteral Formula Storage. J. Parenter. Enter. Nutr. 2005, 29, 204–211. [Google Scholar] [CrossRef] [PubMed]
- Taber, D.F.; Fessel, J.P.; Roberts, L.J. A nomenclature system for isofurans. Prostaglandins Other Lipid Mediat. 2004, 73, 47–50. [Google Scholar] [CrossRef] [PubMed]
- Podolak, A.; Woclawek-Potocka, I.; Lukaszuk, K. The Role of Mitochondria in Human Fertility and Early Embryo Development: What Can We Learn for Clinical Application of Assessing and Improving Mitochondrial DNA? Cells 2022, 11, 797. [Google Scholar] [CrossRef]
- Wang, L.; Zhou, X.; Lu, T. Role of mitochondria in physiological activities, diseases, and therapy. Mol. Biomed. 2025, 6, 42. [Google Scholar] [CrossRef]
- Zong, Y.; Li, H.; Liao, P.; Chen, L.; Pan, Y.; Zheng, Y.; Zhang, C.; Liu, D.; Zheng, M.; Gao, J. Mitochondrial dysfunction: Mechanisms and advances in therapy. Sig. Transduct. Target. Ther. 2024, 9, 124. [Google Scholar] [CrossRef] [PubMed]
- Gaschler, M.M.; Stockwell, B.R. Lipid peroxidation in cell death. Biochem. Biophys. Res. Commun. 2017, 482, 419–425. [Google Scholar] [CrossRef]
- Paradies, G.; Paradies, V.; Ruggiero, F.M.; Petrosillo, G. Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects. Cells 2019, 8, 728. [Google Scholar] [CrossRef]
- Kobayashi, H.; Yoshimoto, C.; Matsubara, S.; Shigetomi, H.; Imanaka, S. Altered Energy Metabolism, Mitochondrial Dysfunction, and Redox Imbalance Influencing Reproductive Performance in Granulosa Cells and Oocyte During Aging. Reprod. Sci. 2024, 31, 906–916. [Google Scholar] [CrossRef]
- Almansa-Ordonez, A.; Bellido, R.; Vassena, R.; Barragan, M.; Zambelli, F. Oxidative Stress in Reproduction: A Mitochondrial Perspective. Biology 2020, 9, 269. [Google Scholar] [CrossRef]
- Ademowo, O.S.; Dias, H.K.I.; Burton, D.G.A.; Griffiths, H.R. Lipid (per) oxidation in mitochondria: An emerging target in the ageing process? Biogerontology 2017, 18, 859–879. [Google Scholar] [CrossRef]
- Agarwal, A.; Rosas, I.M.; Anagnostopoulou, C.; Cannarella, R.; Boitrelle, F.; Munoz, L.V.; Finelli, R.; Durairajanayagam, D.; Henkel, R.; Saleh, R. Oxidative Stress and Assisted Reproduction: A Comprehensive Review of Its Pathophysiological Role and Strategies for Optimizing Embryo Culture Environment. Antioxidants 2022, 11, 477. [Google Scholar] [CrossRef]
- Jin, S.-K.; Yang, W.-X. Factors and pathways involved in capacitation: How are they regulated? Oncotarget 2017, 8, 3600–3627. [Google Scholar] [CrossRef]
- Bao, S.; Yin, T.; Liu, S. Ovarian aging: Energy metabolism of oocytes. J. Ovarian Res. 2024, 17, 118. [Google Scholar] [CrossRef] [PubMed]
- Mannucci, A.; Argento, F.R.; Fini, E.; Coccia, M.E.; Taddei, N.; Becatti, M.; Fiorillo, C. The Impact of Oxidative Stress in Male Infertility. Front. Mol. Biosci. 2022, 8, 799294. [Google Scholar] [CrossRef]
- Bouhadana, D.; Godin Pagé, M.-H.; Montjean, D.; Bélanger, M.-C.; Benkhalifa, M.; Miron, P.; Petrella, F. The Role of Antioxidants in Male Fertility: A Comprehensive Review of Mechanisms and Clinical Applications. Antioxidants 2025, 14, 1013. [Google Scholar] [CrossRef]
- Tsui, K.-H.; Li, C.-J. Mitoquinone shifts energy metabolism to reduce ROS-induced oxeiptosis in female granulosa cells and mouse oocytes. Aging 2023, 15, 246–260. [Google Scholar] [CrossRef]
- Zikopoulos, A.; Christopoulos, P.; Kalampokas, T.; Gerede, A.; Moustakli, E.; Arkoulis, I.; Topis, S.; Potiris, A.; Christodoulaki, C.; Tsakiridis, I.; et al. Oxidative Stress and Inflammatory Biomarkers in Male Infertility: A Narrative Review of Diagnostic Value and Clinical Integration. Diagnostics 2026, 16, 527. [Google Scholar] [CrossRef]
- Schisterman, E.F.; Gaskins, A.J.; Mumford, S.L.; Browne, R.W.; Yeung, E.; Trevisan, M.; Hediger, M.; Zhang, C.; Perkins, N.J.; Hovey, K.; et al. BioCycle Study Group, Influence of endogenous reproductive hormones on F2-isoprostane levels in premenopausal women: The BioCycle Study. Am. J. Epidemiol. 2010, 172, 430–439. [Google Scholar] [CrossRef]
- Gongadashetti, K.; Gupta, P.; Dada, R.; Mahotra, N. Follicular fluid oxidative stress biomarkers and ART outcomes in PCOS women undergoing in vitro fertilization: A cross-sectional study. Int. J. Reprod. Biomed. 2021, 19, 449–456. [Google Scholar] [CrossRef] [PubMed]
- Moreira, M.V.; Vale-Fernandes, E.; Albergaria, I.C.; Alves, M.G.; Monteiro, M.P. Follicular fluid composition and reproductive outcomes of women with polycystic ovary syndrome undergoing in vitro fertilization: A systematic review. Rev. Endocr. Metab. Disord. 2023, 24, 1045–1073. [Google Scholar] [CrossRef] [PubMed]
- Zec, I.; Goldštajn, M.Š.; Kuna, K.; Mikuš, M.; Stabile, G.; Bianco, B.; Buzzaccarini, G.; Laganà, A.S. Oxidative homeostasis in follicular fluid and reproductive outcomes—From bench to bedside. Prezglad Menopauzalny 2022, 21, 276–284. [Google Scholar] [CrossRef]
- Khosrowbeygi, A.; Zarghami, N. Seminal plasma levels of free 8-isoprostane and its relationship with sperm quality parameters. Indian J. Clin. Biochem. 2008, 23, 49–52. [Google Scholar] [CrossRef]
- Barati, E.; Nikzad, H.; Karimian, M. Oxidative stress and male infertility: Current knowledge of pathophysiology and role of antioxidant therapy in disease management. Cell. Mol. Life Sci. 2020, 77, 93–113. [Google Scholar] [CrossRef]
- Halliwell, B.; Lee, C.Y.J. Using Isoprostanes as Biomarkers of Oxidative Stress: Some Rarely Considered Issues. Antioxid. Redox Signal. 2010, 13, 145–156. [Google Scholar] [CrossRef]
- Lin, X.; Dai, Y.; Tong, X.; Xu, W.; Huang, Q.; Jin, X.; Li, C.; Zhou, F.; Zhou, H.; Lin, X.; et al. Excessive oxidative stress in cumulus granulosa cells induced cell senescence contributes to endometriosis-associated infertility. Redox Biol. 2020, 30, 101431. [Google Scholar] [CrossRef]

| Study | Population | Sample | Biomarkers | Method | Main Findings | Clinical Implication |
|---|---|---|---|---|---|---|
| Khosrowbeygi and Zarghami, 2007, [48] | Men with abnormal semen parameters | Seminal plasma | Free 8-isoprostane | Immunoassay | Elevated isoprostane levels associated with reduced motility and abnormal morphology | Reflects oxidative damage to sperm membrane lipids |
| Collodel et al., 2021, [17] | 49 infertile couples undergoing IVF/ICSI | Seminal plasma | F2-isoprostanes | GC/NICI-MS/MS | Positive correlation with double-stranded DNA and embryo quality; negative with chromatin maturity | Indicates role in sperm chromatin integrity and embryo development |
| Moretti et al., 2022, [49] | Infertile men with varicocele, infection, idiopathic infertility | Seminal plasma | F2-isoprostanes | GC/NICI-MS/MS | Defined pathological range and threshold values | Supports diagnostic use in clinical andrology |
| Moretti et al., 2025, [28] | 46 infertile vs. 11 fertile men | Seminal plasma | F2-isoprostanes, MDA, IL-1β | GC-MS, HPLC, ELISA | Strong correlation between oxidative markers; F2-isoprostanes outperform MDA in distinguishing infertility subtypes | Superior biomarker of lipid peroxidation in inflammatory infertility |
| Collodel et al., 2015–2018, [50] | Men with infertility | Seminal plasma/sperm | F2-isoprostanes | GC-MS | Association with lipid peroxidation, sperm immaturity, and oxidative damage | Mechanistic link between ROS and sperm dysfunction |
| Study | Population | Sample | Biomarker | Method | Main Findings | Clinical Implication |
|---|---|---|---|---|---|---|
| Lin et al., 2005, [10] | 29 women undergoing IVF | Follicular fluid | 8,12-iso-iPF2α | LC-MS | Higher levels observed in non-pregnant patients; measurable in FF | Demonstrates feasibility of measuring oxidative stress directly in follicular microenvironment |
| Rosen et al., 2009, [11] | 31 women undergoing ART | Follicular fluid | F2-isoprostanes | GC-MS | Higher levels associated with reduced oocyte number and ovarian ageing | Links oxidative stress with diminished ovarian reserve |
| Kim et al., 2020, [61] | 830 late reproductive-age women | Plasma | F2-isoprostanes | Plasma biomarker analysis | Higher levels associated with lower AMH | Indicates systemic oxidative stress impacts ovarian reserve |
| Nobles et al., 2023, [62] | 1228 women attempting conception | Urine | Multiple isoprostanes | Urinary biomarker analysis | Higher preconception levels associated with lower fecundability | Supports role of oxidative stress in early reproductive success |
| Fujimoto et al., 2011, [12] | 39 IVF patients | Follicular fluid | Lipid peroxidation products | HPLC | No strong association with embryo quality detected | Suggests complexity of oxidative pathways in follicular environment |
| Study | Study Population | Sample | Biomarker(s) | Analytical Method | Main Findings | Clinical Implication |
|---|---|---|---|---|---|---|
| Khosrowbeygi and Zarghami, 2007/2008, [48] | Men with normozoospermia, oligozoospermia, asthenozoospermia, and teratozoospermia | Seminal plasma | Free 8-isoprostane and its hydrolysed form | Immunoassay-based measurement | Free 8-isoprostane showed inverse associations with sperm motility and morphology; higher lipid peroxidation was linked to abnormal semen quality | Supports the use of isoprostanes as markers of sperm membrane oxidative injury |
| Collodel et al., 2021, [17] | 49 infertile couples undergoing IVF/ICSI | Seminal plasma | F2-isoprostanes | GC/NICI-MS/MS | Seminal F2-isoprostanes correlated positively with double-stranded sperm DNA and negatively with mature sperm chromatin; mildly increased levels were associated with better embryo quality in some cases | Indicates that seminal F2-isoprostanes may reflect both oxidative balance and sperm metabolic competence in ART settings |
| Moretti et al., 2022, [49] | 147 infertile men with varicocele, urogenital infection, or idiopathic infertility, and 45 fertile controls | Seminal plasma | F2-isoprostanes | GC/NICI-MS/MS | Established a pathological range and proposed a cut-off distinguishing physiological from abnormal seminal F2-isoprostane levels | Strengthens the clinical applicability of seminal F2-isoprostanes as a diagnostic oxidative stress biomarker |
| Moretti et al., 2025, [28] | 46 infertile men with varicocele, genitourinary infection, or idiopathic infertility, and 11 fertile controls | Seminal plasma | F2-isoprostanes, MDA, IL-1β | GC/NICI-MS for F2-isoprostanes; HPLC for MDA; ELISA for IL-1β | F2-isoprostanes, MDA, and IL-1β were all increased in inflammatory infertility states, but F2-isoprostanes discriminated pathological groups more accurately than MDA, especially idiopathic infertility | Supports F2-isoprostanes as a more informative marker of semen lipid peroxidation than MDA in inflammatory male infertility |
| Kim et al., 2020, [61] | 830 late reproductive-age women from the CARDIA cohort | Plasma | F2-isoprostanes | Plasma biomarker analysis in epidemiologic cohort | Higher circulating F2-isoprostanes were associated with lower AMH levels, especially at younger reproductive ages | Suggests a link between systemic oxidative stress and diminished ovarian reserve |
| Nobles et al., 2023, [62] | 1228 women attempting conception in the EAGeR trial | Urine | 8-iso-PGF2α, 2,3-dinor-iPF2α-III, 5-iso-PGF2α-VI, 8,12-iso-iPF2α-VI | Urinary isoprostane measurement | Higher preconception isoprostane levels were associated with lower fecundability; early gestational levels rose thereafter and showed a complex association with pregnancy loss | Supports the relevance of isoprostanes as peripheral biomarkers of redox status in natural fertility and early pregnancy |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Voros, C.; Chatzinikolaou, F.; Papadimas, G.; Karpouzos, A.; Koulakmanidis, A.-M.; Athanasiou, D.; Bananis, K.; Athanasiou, A.; Athanasiou, A.; Tsimpoukelis, C.; et al. Isoprostanes and Isofurans in Infertility and Assisted Reproduction: What Do We Know So Far? Int. J. Mol. Sci. 2026, 27, 4710. https://doi.org/10.3390/ijms27114710
Voros C, Chatzinikolaou F, Papadimas G, Karpouzos A, Koulakmanidis A-M, Athanasiou D, Bananis K, Athanasiou A, Athanasiou A, Tsimpoukelis C, et al. Isoprostanes and Isofurans in Infertility and Assisted Reproduction: What Do We Know So Far? International Journal of Molecular Sciences. 2026; 27(11):4710. https://doi.org/10.3390/ijms27114710
Chicago/Turabian StyleVoros, Charalampos, Fotios Chatzinikolaou, Georgios Papadimas, Athanasios Karpouzos, Aristotelis-Marios Koulakmanidis, Diamantis Athanasiou, Kyriakos Bananis, Antonia Athanasiou, Aikaterini Athanasiou, Charalampos Tsimpoukelis, and et al. 2026. "Isoprostanes and Isofurans in Infertility and Assisted Reproduction: What Do We Know So Far?" International Journal of Molecular Sciences 27, no. 11: 4710. https://doi.org/10.3390/ijms27114710
APA StyleVoros, C., Chatzinikolaou, F., Papadimas, G., Karpouzos, A., Koulakmanidis, A.-M., Athanasiou, D., Bananis, K., Athanasiou, A., Athanasiou, A., Tsimpoukelis, C., Papapanagiotou, I., Daskalaki, M. A., Trakateli, C., Koranteng, N. K., Thomakos, N., Antsaklis, P., Loutradis, D., & Daskalakis, G. (2026). Isoprostanes and Isofurans in Infertility and Assisted Reproduction: What Do We Know So Far? International Journal of Molecular Sciences, 27(11), 4710. https://doi.org/10.3390/ijms27114710

